J. Romero and J. Newland, Viral meningitis and encephalitis: Traditional and emerging viral agents, Seminars in Pediatric Infectious Diseases, vol.14, issue.2, pp.72-82, 2003.
DOI : 10.1053/spid.2003.127223

P. Ceccaldi, J. Gillet, and H. Tsiang, Inhibition of the Transport of Rabies Virus in the Central Nervous System, Journal of Neuropathology & Experimental Neurology, vol.48, issue.6, pp.620-650, 1989.
DOI : 10.1097/00005072-198911000-00004

P. Ceccaldi, M. Lucas, and P. Despres, New insights on the neuropathogenicity of West Nile virus, FEMS Microbiology Letters, vol.233, issue.1, pp.1-6, 2004.
DOI : 10.1016/j.femsle.2004.01.035

E. Neuwelt, B. Bauer, C. Fahlke, G. Fricker, C. Iadecola et al., Engaging neuroscience to advance translational research in brain barrier biology, Nature Reviews Neuroscience, vol.121, issue.3, pp.169-82, 2011.
DOI : 10.1038/nrn2995

M. Cipolla, The Cerebral Circulation, Colloquium Series on Integrated Systems Physiology: From Molecule to Function, vol.1, issue.1, 2009.
DOI : 10.4199/C00005ED1V01Y200912ISP002

B. Zlokovic, Neurovascular mechanisms of Alzheimer's neurodegeneration, Trends in Neurosciences, vol.28, issue.4, pp.202-210, 2005.
DOI : 10.1016/j.tins.2005.02.001

W. Pan and A. Kastin, Why study transport of peptides and proteins at the neurovascular interface, Brain Research Reviews, vol.46, issue.1, pp.32-43, 2004.
DOI : 10.1016/j.brainresrev.2004.04.006

D. Begley and M. Brightman, Structural and functional aspects of the blood-brain barrier, Prog Drug Res, vol.61, pp.39-7814674608, 2003.
DOI : 10.1007/978-3-0348-8049-7_2

T. Reese and M. Karnovsky, FINE STRUCTURAL LOCALIZATION OF A BLOOD-BRAIN BARRIER TO EXOGENOUS PEROXIDASE, The Journal of Cell Biology, vol.34, issue.1, pp.207-224, 1967.
DOI : 10.1083/jcb.34.1.207

D. Bonkowski, V. Katyshev, R. Balabanov, A. Borisov, and P. Dore-duffy, The CNS microvascular pericyte: pericyte-astrocyte crosstalk in the regulation of tissue survival, Fluids and Barriers of the CNS, vol.8, issue.1, 2011.
DOI : 10.1186/2045-8118-8-8

S. Nag, Morphology and Properties of Astrocytes, Methods Mol Biol, vol.686, pp.69-100978, 2011.
DOI : 10.1007/978-1-60761-938-3_3

N. Weiss, F. Miller, S. Cazaubon, and P. Couraud, The blood-brain barrier in brain homeostasis and neurological diseases, Biochimica et Biophysica Acta (BBA) - Biomembranes, vol.1788, issue.4, pp.842-57, 2009.
DOI : 10.1016/j.bbamem.2008.10.022

J. Correale and A. Villa, Cellular Elements of the Blood-Brain Barrier, Neurochemical Research, vol.51, issue.12, pp.2067-77, 2009.
DOI : 10.1007/s11064-009-0081-y

M. Brightman and T. Reese, JUNCTIONS BETWEEN INTIMATELY APPOSED CELL MEMBRANES IN THE VERTEBRATE BRAIN, The Journal of Cell Biology, vol.40, issue.3, pp.648-77, 1969.
DOI : 10.1083/jcb.40.3.648

U. Bickel, T. Yoshikawa, and W. Pardridge, Delivery of peptides and proteins through the blood???brain barrier, Advanced Drug Delivery Reviews, vol.46, issue.1-3, pp.247-79, 2001.
DOI : 10.1016/S0169-409X(00)00139-3

W. Löscher and H. Potschka, Drug resistance in brain diseases and the role of drug efflux transporters, Nature Reviews Neuroscience, vol.79, issue.8, pp.591-602, 2005.
DOI : 10.2174/1389200043489199

B. Engelhardt and H. Wolburg, Mini-review: Transendothelial migration of leukocytes: through the front door or around the side of the house?, European Journal of Immunology, vol.105, issue.11, pp.2955-63, 2004.
DOI : 10.1002/eji.200425327

X. Nassif, S. Bourdoulous, E. Eugène, and P. Couraud, How do extracellular pathogens cross the blood???brain barrier?, Trends in Microbiology, vol.10, issue.5, pp.227-259, 2002.
DOI : 10.1016/S0966-842X(02)02349-1

R. Janssen, O. Nwanyanwu, R. Selik, and J. Stehr-green, Epidemiology of human immunodeficiency virus encephalopathy in the United States, Neurology, vol.42, issue.8, pp.1472-61641138, 1992.
DOI : 10.1212/WNL.42.8.1472

M. Reger, R. Welsh, J. Razani, D. Martin, and K. Boone, A meta-analysis of the neuropsychological sequelae of HIV infection, Journal of the International Neuropsychological Society, vol.8, issue.03, pp.410-434, 2002.
DOI : 10.1017/S1355617702813212

B. Navia, E. Cho, C. Petito, and R. Price, The AIDS dementia complex: II. Neuropathology, Annals of Neurology, vol.7, issue.6, pp.525-560, 1986.
DOI : 10.1002/ana.410190603

B. Navia, B. Jordan, and R. Price, The AIDS dementia complex: I. Clinical features, Annals of Neurology, vol.100, issue.6, pp.517-541, 1986.
DOI : 10.1002/ana.410190602

C. Wiley, R. Schrier, M. Morey, C. Achim, J. Venable et al., Pathogenesis of HIV Encephalitis, Pathology International, vol.135, issue.3, pp.192-62068943, 1991.
DOI : 10.1111/j.1440-1827.1991.tb01646.x

M. Toborek, Y. Lee, G. Flora, H. Pu, I. András et al., Mechanisms of the Blood???Brain Barrier Disruption in HIV-1 Infection, Cellular and Molecular Neurobiology, vol.14, issue.Suppl. 1, pp.181-99, 2005.
DOI : 10.1007/s10571-004-1383-x

H. Budka, The Definition of HIV-specific Neuropathology, Pathology International, vol.49, issue.3, pp.182-91, 1991.
DOI : 10.1111/j.1440-1827.1991.tb01645.x

M. Tardieu, HIV-1-related central nervous system diseases, Current Opinion in Neurology, vol.12, issue.4, pp.377-81, 1999.
DOI : 10.1097/00019052-199908000-00002

E. Singer, K. Syndulko, B. Fahy-chandon, P. Schmid, A. Conrad et al., Intrathecal IgG synthesis and albumin leakage are increased in subjects with HIV-1 neurologic disease, J Acquir Immune Defic Syndr, vol.7, pp.265-717906304, 1994.

M. Avison, A. Nath, and J. Berger, Understanding pathogenesis and treatment of HIV dementia: a role for magnetic resonance?, Trends in Neurosciences, vol.25, issue.9, pp.468-73, 2002.
DOI : 10.1016/S0166-2236(02)02234-8

L. Dallasta, L. Pisarov, J. Esplen, J. Werley, A. Moses et al., Blood-Brain Barrier Tight Junction Disruption in Human Immunodeficiency Virus-1 Encephalitis, The American Journal of Pathology, vol.155, issue.6, pp.1915-1942, 1999.
DOI : 10.1016/S0002-9440(10)65511-3

L. Boven, J. Middel, J. Verhoef, D. Groot, C. Nottet et al., Monocyte infiltration is highly associated with loss of the tight junction protein zonula occludens in HIV-1-associated dementia, Neuropathology and Applied Neurobiology, vol.31, issue.4, pp.356-60, 2000.
DOI : 10.1016/S0301-0082(97)00053-1

T. Mogensen and S. Paludan, Virus-cell interactions: impact on cytokine production, immune evasion and tumor growth, Eur Cytokine Netw, vol.12, pp.382-9011566618, 2001.

T. Mogensen and S. Paludan, Molecular Pathways in Virus-Induced Cytokine Production, Microbiology and Molecular Biology Reviews, vol.65, issue.1, pp.131-50, 2001.
DOI : 10.1128/MMBR.65.1.131-150.2001

D. Gabuzda and R. Sobel, HIV antigen in brains of patients with AIDS, Annals of Neurology, vol.83, issue.5, p.668, 1987.
DOI : 10.1002/ana.410220526

P. Cinque, L. Vago, M. Mengozzi, V. Torri, D. Ceresa et al., Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication, AIDS, vol.12, issue.11, pp.1327-329708412, 1998.
DOI : 10.1097/00002030-199811000-00014

S. Bernasconi, P. Cinque, G. Peri, S. Sozzani, A. Crociati et al., Selective Elevation of Monocyte Chemotactic Protein-1 in the Cerebrospinal Fluid of AIDS Patients with Cytomegalovirus Encephalitis, Journal of Infectious Diseases, vol.174, issue.5, pp.1098-1018896515, 1996.
DOI : 10.1093/infdis/174.5.1098

K. Conant, J. Mcarthur, D. Griffin, L. Sjulson, L. Wahl et al., Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia, Annals of Neurology, vol.161, issue.3, pp.391-399, 1999.
DOI : 10.1002/1531-8249(199909)46:3<391::AID-ANA15>3.0.CO;2-0

D. Marshall, T. Wyss-coray, and C. Abraham, Induction of matrix metalloproteinase-2 in human immunodeficiency virus-1 glycoprotein 120 transgenic mouse brains, Neuroscience Letters, vol.254, issue.2, pp.97-100, 1998.
DOI : 10.1016/S0304-3940(98)00674-0

B. Sporer, R. Paul, U. Koedel, R. Grimm, M. Wick et al., Presence of Matrix Metalloproteinase???9 Activity in the Cerebrospinal Fluid of Human Immunodeficiency Virus???Infected Patients, The Journal of Infectious Diseases, vol.178, issue.3, pp.854-861, 1998.
DOI : 10.1086/515342

B. Weeks, D. Lieberman, B. Johnson, E. Roque, M. Green et al., Neurotoxicity of the human immunodeficiency virus type 1 Tat transactivator to PC12 cells requires the Tat amino acid 49-58 basic domain, Journal of Neuroscience Research, vol.268, issue.1, pp.34-40, 1995.
DOI : 10.1002/jnr.490420105

L. Hudson, J. Liu, A. Nath, M. Jones, R. Raghavan et al., in CNS tissues, Journal of Neurovirology, vol.6, issue.2, pp.145-55, 2000.
DOI : 10.3109/13550280009013158

M. Arese, C. Ferrandi, L. Primo, G. Camussi, and F. Bussolino, HIV-1 Tat Protein Stimulates In Vivo Vascular Permeability and Lymphomononuclear Cell Recruitment, The Journal of Immunology, vol.166, issue.2, pp.1380-811145723, 2001.
DOI : 10.4049/jimmunol.166.2.1380

T. Oshima, S. Flores, G. Vaitaitis, L. Coe, T. Joh et al., HIV-1 Tat increases endothelial solute permeability through tyrosine kinase and mitogen-activated protein kinase-dependent pathways, AIDS, vol.14, issue.5, pp.475-82, 2000.
DOI : 10.1097/00002030-200003310-00002

H. Pu, J. Tian, G. Flora, Y. Lee, A. Nath et al., HIV-1 tat protein upregulates inflammatory mediators and induces monocyte invasion into the brain, Molecular and Cellular Neuroscience, vol.24, issue.1, pp.224-261, 2003.
DOI : 10.1016/S1044-7431(03)00171-4

I. András, H. Pu, M. Deli, A. Nath, B. Hennig et al., HIV-1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells, Journal of Neuroscience Research, vol.14, issue.Suppl, pp.255-65, 2003.
DOI : 10.1002/jnr.10762

M. Toborek, Y. Lee, H. Pu, A. Malecki, G. Flora et al., HIV-Tat protein induces oxidative and inflammatory pathways in brain endothelium, Journal of Neurochemistry, vol.14, issue.1, pp.169-79, 2003.
DOI : 10.1046/j.1471-4159.2003.01543.x

B. Shi, D. Girolami, U. He, J. Wang, S. Lorenzo et al., Apoptosis induced by HIV-1 infection of the central nervous system., Journal of Clinical Investigation, vol.98, issue.9, pp.1979-908903316, 1996.
DOI : 10.1172/JCI119002

E. Acheampong, Z. Parveen, L. Muthoga, M. Kalayeh, M. Mukhtar et al., Human Immunodeficiency Virus Type 1 Nef Potently Induces Apoptosis in Primary Human Brain Microvascular Endothelial Cells via the Activation of Caspases, Journal of Virology, vol.79, issue.7, pp.4257-69, 2005.
DOI : 10.1128/JVI.79.7.4257-4269.2005

T. Price, N. Ercal, R. Nakaoke, and W. Banks, HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells, Brain Research, vol.1045, issue.1-2, pp.57-63, 2005.
DOI : 10.1016/j.brainres.2005.03.031

G. Kanmogne, C. Primeaux, and P. Grammas, HIV-1 gp120 Proteins Alter Tight Junction Protein Expression and Brain Endothelial Cell Permeability: Implications for the Pathogenesis of HIV-Associated Dementia, Journal of Neuropathology & Experimental Neurology, vol.64, issue.6, pp.498-505, 2005.
DOI : 10.1093/jnen/64.6.498

S. Nakamuta, H. Endo, Y. Higashi, A. Kousaka, H. Yamada et al., Human immunodeficiency virus type 1 gp120???mediated disruption of tight junction proteins by induction of proteasome-mediated degradation of zonula occludens-1 and -2 in human brain microvascular endothelial cells, Journal of Neurovirology, vol.14, issue.3, pp.186-95, 2008.
DOI : 10.1080/13550280801993630

G. Kanmogne, K. Schall, J. Leibhart, B. Knipe, H. Gendelman et al., HIV-1 gp120 Compromises Blood???Brain Barrier Integrity and Enhance Monocyte Migration across Blood???Brain Barrier: Implication for Viral Neuropathogenesis, Journal of Cerebral Blood Flow & Metabolism, vol.278, issue.1, pp.123-157, 2007.
DOI : 10.1038/381661a0

J. Rottman, K. Ganley, K. Williams, L. Wu, C. Mackay et al., Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV- 1 infection, Am J Pathol, vol.151, pp.1341-51, 1997.

V. Sanders, C. Pittman, M. White, G. Wang, C. Wiley et al., Chemokines and receptors in HIV encephalitis, AIDS, vol.12, issue.9, pp.1021-1027, 1998.
DOI : 10.1097/00002030-199809000-00009

A. Moses, F. Bloom, C. Pauza, and J. Nelson, Human immunodeficiency virus infection of human brain capillary endothelial cells occurs via a CD4/galactosylceramide-independent mechanism., Proceedings of the National Academy of Sciences, vol.90, issue.22, pp.10474-87504264, 1993.
DOI : 10.1073/pnas.90.22.10474

A. Moses and J. Nelson, HIV infection of human brain capillary endothelial cell ??? Implications for AIDS dementia, Advances in Neuroimmunology, vol.4, issue.3, pp.239-286, 1994.
DOI : 10.1016/S0960-5428(06)80262-7

S. Rostad, S. Sumi, C. Shaw, K. Olson, and J. Mcdougall, Human Immunodeficiency Virus (HIV) Infection in Brains with AIDS-Related Leukoencephalopathy, AIDS Research and Human Retroviruses, vol.3, issue.4, pp.363-733447627, 1987.
DOI : 10.1089/aid.1987.3.363

J. Ward, O. Leary, T. Baskin, G. Benveniste, R. Harris et al., Immunohistochemical localization of human and simian immunodeficiency viral antigens in fixed tissue sections, Am J Pathol, vol.127, pp.199-2053472469, 1987.

C. Wiley, R. Schrier, J. Nelson, P. Lampert, and M. Oldstone, Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients., Proceedings of the National Academy of Sciences, vol.83, issue.18, pp.7089-93, 1986.
DOI : 10.1073/pnas.83.18.7089

K. Takahashi, S. Wesselingh, D. Griffin, J. Mcarthur, R. Johnson et al., Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry, Annals of Neurology, vol.38, issue.6, pp.705-716, 1996.
DOI : 10.1002/ana.410390606

Y. Liu, X. Tang, J. Mcarthur, J. Scott, and S. Gartner, Analysis of human immunodeficiency virus type 1 gp160 sequences from a patient with HIV dementia: evidence for monocyte trafficking into brain, J Neurovirol, vol.6, pp.70-8110871768, 2000.

B. Engelhardt and R. Ransohoff, The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms, Trends in Immunology, vol.26, issue.9, pp.485-95, 2005.
DOI : 10.1016/j.it.2005.07.004

G. Gras and M. Kaul, Molecular mechanisms of neuroinvasion by monocytes-macrophages in HIV-1 infection, Retrovirology, vol.7, issue.1, 2010.
DOI : 10.1186/1742-4690-7-30

D. Wu, S. Woodman, J. Weiss, C. Mcmanus, D. Aversa et al., Mechanisms of leukocyte trafficking into the CNS, J Neurovirol, vol.6, pp.82-510871769, 2000.

M. Jones, J. Bell, and A. Nath, Immunolocalization of HIV envelope gp120 in HIV encephalitis with dementia, AIDS, vol.14, issue.17, pp.2709-2722, 2000.
DOI : 10.1097/00002030-200012010-00010

L. Fantuzzi, F. Spadaro, G. Vallanti, I. Canini, C. Ramoni et al., Endogenous CCL2 (monocyte chemotactic protein-1) modulates human immunodeficiency virus type-1 replication and affects cytoskeleton organization in human monocyte-derived macrophages, Blood, vol.102, issue.7, pp.2334-2341, 2003.
DOI : 10.1182/blood-2002-10-3275

E. Gonzalez, B. Rovin, L. Sen, G. Cooke, R. Dhanda et al., HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels, Proceedings of the National Academy of Sciences, vol.99, issue.21, pp.13795-800, 2002.
DOI : 10.1073/pnas.202357499

A. Yadav and R. Collman, CNS Inflammation and Macrophage/Microglial Biology Associated with HIV-1 Infection, Journal of Neuroimmune Pharmacology, vol.293, issue.Suppl 1, pp.430-477, 2009.
DOI : 10.1007/s11481-009-9174-2

W. Banks, A. Kastin, J. Brennan, and K. Vallance, Adsorptive Endocytosis of HIV-1gp120 by Blood???Brain Barrier Is Enhanced by Lipopolysaccharide, Experimental Neurology, vol.156, issue.1, pp.165-717011, 1998.
DOI : 10.1006/exnr.1998.7011

H. Stolp, K. Dziegielewska, C. Ek, A. Potter, and N. Saunders, Long-term changes in blood-brain barrier permeability and white matter following prolonged systemic inflammation in early development in the rat, European Journal of Neuroscience, vol.55, issue.11, pp.2805-2821, 2005.
DOI : 10.1111/j.1460-9568.2005.04483.x

Y. Persidsky, M. Stins, D. Way, M. Witte, M. Weinand et al., A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis, J Immunol, vol.158, pp.3499-5109120312, 1997.

H. Wang, J. Sun, and H. Goldstein, Human Immunodeficiency Virus Type 1 Infection Increases the In Vivo Capacity of Peripheral Monocytes To Cross the Blood-Brain Barrier into the Brain and the In Vivo Sensitivity of the Blood-Brain Barrier to Disruption by Lipopolysaccharide, Journal of Virology, vol.82, issue.15, pp.7591-60000768, 2008.
DOI : 10.1128/JVI.00768-08

G. Baskin, M. Murphey-corb, E. Watson, and L. Martin, Necropsy Findings in Rhesus Monkeys Experimentally Infected with Cultured Simian Immunodeficiency Virus (SIV)/Delta, Veterinary Pathology, vol.127, issue.6, pp.456-67, 1988.
DOI : 10.1177/030098588802500609

L. Sharer, G. Baskin, E. Cho, M. Murphey-corb, B. Blumberg et al., Comparison of simian immunodeficiency virus and human immunodeficiency virus encephalitides in the immature host, Annals of Neurology, vol.155, issue.S1
DOI : 10.1002/ana.410230727

L. Chakrabarti, M. Hurtrel, M. Maire, R. Vazeux, D. Dormont et al., Early viral replication in the brain of SIV-infected rhesus monkeys, Am J Pathol, vol.139, pp.1273-801750503, 1991.

M. Luabeya, L. Dallasta, C. Achim, C. Pauza, R. Hamilton et al., Blood-brain barrier disruption in simian immunodeficiency virus encephalitis, Neuropathology and Applied Neurobiology, vol.36, issue.5, pp.454-62337, 2000.
DOI : 10.1083/jcb.103.3.755

A. Steffan, M. Lafon, J. Gendrault, F. Koehren, D. Monte et al., Feline immunodeficiency virus can productively infect cultured endothelial cells from cat brain microvessels, Journal of General Virology, vol.75, issue.12, pp.3647-537996160, 1994.
DOI : 10.1099/0022-1317-75-12-3647

N. Fletcher, R. Meeker, L. Hudson, and J. Callanan, The neuropathogenesis of feline immunodeficiency virus infection: Barriers to overcome, The Veterinary Journal, vol.188, issue.3, pp.260-269, 2011.
DOI : 10.1016/j.tvjl.2010.03.022

G. Georgsson, Neuropathologic Aspects of Lentiviral Infections, Annals of the New York Academy of Sciences, vol.149, issue.1 Slow Infectio, pp.50-67, 1994.
DOI : 10.1038/335178a0

M. Zink, J. Yager, and J. Myers, Pathogenesis of caprine arthritis encephalitis virus. Cellular localization of viral transcripts in tissues of infected goats, Am J Pathol, vol.136, pp.843-542327471, 1990.

M. Osame, S. Izumo, A. Igata, M. Matsumoto, T. Matsumoto et al., BLOOD TRANSFUSION AND HTLV-I ASSOCIATED MYELOPATHY, The Lancet, vol.328, issue.8498, pp.104-109, 1986.
DOI : 10.1016/S0140-6736(86)91636-3

M. Osame, K. Usuku, S. Izumo, N. Ijichi, H. Amitani et al., HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITY, The Lancet, vol.327, issue.8488, pp.1031-1033, 1986.
DOI : 10.1016/S0140-6736(86)91298-5

A. Gessain, F. Barin, J. Vernant, O. Gout, L. Maurs et al., ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS, The Lancet, vol.326, issue.8452, pp.407-417, 1985.
DOI : 10.1016/S0140-6736(85)92734-5

M. Jernigan, Y. Morcos, S. Lee, F. Dohan, J. Raine et al., IgG in brain correlates with clinicopathological damage in HTLV-1 associated neurologic disease, Neurology, vol.60, issue.8, pp.1320-712707436, 2003.
DOI : 10.1212/01.WNL.0000059866.03880.BA

S. Ozden, D. Seilhean, A. Gessain, J. Hauw, and O. Gout, Severe Demyelinating Myelopathy with Low Human T Cell Lymphotropic Virus Type 1 Expression after Transfusion in an Immunosuppressed Patient, Clinical Infectious Diseases, vol.34, issue.6, pp.855-60, 2002.
DOI : 10.1086/338868

L. Cartier and E. Ramirez, Presence of HTLV-I Tax protein in cerebrospinal fluid from HAM/TSP patients, Archives of Virology, vol.150, issue.4, pp.743-53, 2005.
DOI : 10.1007/s00705-004-0443-3

M. Cavrois, A. Gessain, O. Gout, S. Wain-hobson, and E. Wattel, Common Human T Cell Leukemia Virus Type 1 (HTLV???1) Integration Sites in Cerebrospinal Fluid and Blood Lymphocytes of Patients with HTLV???1???Associated Myelopathy/Tropical Spastic Paraparesis Indicate that HTLV???1 Crosses the Blood???Brain Barrier via Clonal HTLV???1???Infected Cells, The Journal of Infectious Diseases, vol.182, issue.4, pp.1044-50315844, 2000.
DOI : 10.1086/315844

Y. Kuroda, M. Matsui, H. Takashima, and K. Kurohara, Granulocyte-macrophage colony-stimulating factor and interleukin-1 increase in cerebrospinal fluid, but not in serum, of HTLV-I-associated myelopathy, Journal of Neuroimmunology, vol.45, issue.1-2, pp.133-60165, 1993.
DOI : 10.1016/0165-5728(93)90173-V

Y. Kuroda and M. Matsui, Cerebrospinal fluid interferon-gamma is increased in HTLV-I-associated myelopathy, Journal of Neuroimmunology, vol.42, issue.2, pp.223-60165, 1993.
DOI : 10.1016/0165-5728(93)90014-P

S. Nakamura, I. Nagano, M. Yoshioka, S. Shimazaki, J. Onodera et al., Detection of tumor necrosis factor-??-positive cells in cerebrospinal fluid of patients with HTLV-I-associated myelopathy, Journal of Neuroimmunology, vol.42, issue.2, pp.127-300165, 1993.
DOI : 10.1016/0165-5728(93)90001-F

C. Brosnan, K. Selmaj, and C. Raine, Hypothesis: A role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis, Journal of Neuroimmunology, vol.18, issue.1, pp.87-940165, 1988.
DOI : 10.1016/0165-5728(88)90137-3

T. Lehky, C. Fox, S. Koenig, M. Levin, N. Flerlage et al., Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization, Annals of Neurology, vol.2, issue.2, pp.167-757847858, 1995.
DOI : 10.1002/ana.410370206

S. Jacobson, Immunopathogenesis of Human T Cell Lymphotropic Virus Type I???Associated Neurologic Disease, The Journal of Infectious Diseases, vol.186, issue.s2, pp.187-92, 2002.
DOI : 10.1086/344269

S. Muller, G. Boire, M. Ossondo, V. Ricchiuti, D. Smadja et al., IgG Autoantibody Response in HTLV-I-Infected Patients, Clinical Immunology and Immunopathology, vol.77, issue.3, pp.282-9075867381154, 1995.
DOI : 10.1006/clin.1995.1154

I. Romero, M. Prevost, E. Perret, P. Adamson, J. Greenwood et al., Interactions between Brain Endothelial Cells and Human T-Cell Leukemia Virus Type 1-Infected Lymphocytes: Mechanisms of Viral Entry into the Central Nervous System, Journal of Virology, vol.74, issue.13, pp.6021-6051, 2000.
DOI : 10.1128/JVI.74.13.6021-6030.2000

P. Afonso, S. Ozden, M. Prevost, C. Schmitt, D. Seilhean et al., Human Blood-Brain Barrier Disruption by Retroviral-Infected Lymphocytes: Role of Myosin Light Chain Kinase in Endothelial Tight-Junction Disorganization, The Journal of Immunology, vol.179, issue.4, pp.2576-8317675520, 2007.
DOI : 10.4049/jimmunol.179.4.2576

URL : https://hal.archives-ouvertes.fr/pasteur-00364081

S. Khuth, N. Strazielle, P. Giraudon, M. Belin, and J. Ghersi-egea, Impairment of blood-cerebrospinal fluid barrier properties by retrovirus-activated T lymphocytes: reduction in cerebrospinal fluid-to-blood efflux of prostaglandin E2, Journal of Neurochemistry, vol.89, issue.6, pp.1580-93, 2005.
DOI : 10.1128/JVI.74.14.6433-6441.2000

P. Afonso, S. Ozden, M. Cumont, D. Seilhean, L. Cartier et al., Alteration of Blood???Brain Barrier Integrity by Retroviral Infection, PLoS Pathogens, vol.58, issue.11, 2008.
DOI : 10.1371/journal.ppat.1000205.g006

URL : https://hal.archives-ouvertes.fr/pasteur-00363900

A. Lezin, N. Gillet, S. Olindo, A. Signaté, N. Grandvaux et al., Histone deacetylase mediated transcriptional activation reduces proviral loads in HTLV-1 associated myelopathy/tropical spastic paraparesis patients, Blood, vol.110, issue.10, pp.3722-3730, 2007.
DOI : 10.1182/blood-2007-04-085076

L. Boissé, M. Gill, and C. Power, HIV Infection of the Central Nervous System: Clinical Features and Neuropathogenesis, Neurologic Clinics, vol.26, issue.3, pp.799-81918657727, 2008.
DOI : 10.1016/j.ncl.2008.04.002

I. Anthony and J. Bell, The Neuropathology of HIV/AIDS, International Review of Psychiatry, vol.63, issue.1, pp.15-24, 2008.
DOI : 10.1097/00002030-200401001-00011

S. Mahajan, R. Aalinkeel, D. Sykes, J. Reynolds, B. Bindukumar et al., Tight Junction Regulation by Morphine and HIV-1 Tat Modulates Blood???Brain Barrier Permeability, Journal of Clinical Immunology, vol.110, issue.6, pp.528-569, 2008.
DOI : 10.1007/s10875-008-9208-1

L. Zhang, D. Looney, D. Taub, S. Chang, D. Way et al., Cocaine opens the blood-brain barrier to HIV-1 invasion, Journal of Neurovirology, vol.4, issue.6, pp.619-645, 1998.
DOI : 10.3109/13550289809114228

M. Fiala, X. Gan, L. Zhang, S. House, T. Newton et al., Cocaine Enhances Monocyte Migration Across the Blood-Brain Barrier, Adv Exp Med Biol, vol.437, pp.199-2059666272978, 1998.
DOI : 10.1007/978-1-4615-5347-2_22

N. Gandhi, Z. Saiyed, J. Napuri, T. Samikkannu, P. Reddy et al., Interactive role of human immunodeficiency virus type 1 (HIV-1) clade-specific Tat protein and cocaine in blood-brain barrier dysfunction: Implications for HIV-1???associated neurocognitive disorder, Journal of Neurovirology, vol.16, issue.4, pp.294-305, 2010.
DOI : 10.3109/13550284.2010.499891

V. Manda, R. Mittapalli, K. Bohn, C. Adkins, and P. Lockman, Nicotine and cotinine increases the brain penetration of saquinavir in rat, Journal of Neurochemistry, vol.590, issue.6, pp.1495-507, 2010.
DOI : 10.1111/j.1471-4159.2010.07054.x

V. Manda, R. Mittapalli, W. Geldenhuys, and P. Lockman, Chronic exposure to nicotine and saquinavir decreases endothelial Notch-4 expression and disrupts blood-brain barrier integrity, Journal of Neurochemistry, vol.57, issue.Suppl 1, pp.515-540, 2010.
DOI : 10.1111/j.1471-4159.2010.06948.x